![china-med-device-logo-rev_c80e4f9e9f2d285c4b08ea5c15ae79c4[1]](https://chinameddevice.com/wp-content/uploads/2018/09/china-med-device-logo-rev_c80e4f9e9f2d285c4b08ea5c15ae79c41.png){kind=logo}
October 14, 2018
For the first time in 2018, NMPA (formerly CFDA) issued clinical trial incompliant companies report. In this Medical Device Clinical Audit Notice on September 12th, Siemens and Medtronic, along with […]
October 8, 2018
Thanks for taking the time to visit China Med Device at the RAPS Convergence in Vancouver. I appreciate the opportunity to share some of the latest developments at NMPA (CFDA) […]
October 4, 2018
The price of high-value medical consumables is relatively high. These consumables are usually used for special treatments like cardiac intervention therapy, peripheral vascular intervention, artificial joints replacement, and other organ […]
October 1, 2018
NPMA (formerly CFDA) published the “Clinical Exemption Catalog for Medical Devices” yesterday (Sep 30th), in which a total of 855 medical devices and 393 IVDs exempted from clinical trial. It […]
September 27, 2018
Visit China Med Device at RAPS October 1 – 4th in Vancouver and Get the Latest Update on NMPA (formerly CFDA) and a Glamor Shot! China Med Device, LLC is […]